Which Endpoints Should We Use in Evaluating the Use of Novel Fluoropyrimidine Regimens in Colorectal Cancer?
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600341
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2002
Authors
Publisher
Springer Science and Business Media LLC